Table 4.
Variables | Group N (%) |
OR (95% CI) | p-value | |
---|---|---|---|---|
Intention to receive vaccines (N = 158) | No intention to receive vaccines (N = 353) | |||
Sex | ||||
Female | 130 (82.3%) | 261 (73.9%) | 1.6 (1.0–2.7) | 0.040 |
Male |
28 (17.7%) |
92 (26.1%) |
0.6 (0.4–1.0) |
0.040 |
Religion | ||||
Buddhism | 123 (77.8%) | 281 (79.6%) | 0.9 (0.6–1.5) | 0.652 |
Muslim | 34 (21.5%) | 64 (18.1%) | 1.2 (0.8–2.0) | 0.369 |
Others |
1 (0.6%) |
8 (2.3%) |
0.3 (0.0–2.1) |
0.195 |
Major | ||||
Health-related | 77 (48.7%) | 155 (43.9%) | 1.2 (0.8–1.8) | 0.311 |
Non-health related |
81 (51.3%) |
198 (56.1%) |
0.8 (0.6–1.2) |
0.311 |
Year of study | ||||
1st year | 49 (31.0%) | 166 (47.0%) | 0.5 (0.3–0.8) | 0.001 |
2nd year | 53 (33.5%) | 97 (27.5%) | 1.3 (0.9–2.0) | 0.164 |
3rd year | 28 (17.7%) | 44 (12.5%) | 1.5 (0.9–2.6) | 0.114 |
4th year | 25 (15.8%) | 41 (11.6%) | 1.4 (0.8–2.5) | 0.190 |
5th year or more |
3 (1.9%) |
5 (1.4%) |
1.4 (0.2–7.0) |
0.685 |
Family's monthly income (USD) | ||||
<500 | 25 (15.8%) | 73 (20.7%) | 0.7 (0.4–1.2) | 0.197 |
500–1000 | 69 (43.7%) | 162 (45.9%) | 0.9 (0.6–1.4) | 0.641 |
1001–1500 | 32 (20.3%) | 71 (20.1%) | 1.0 (0.6–1.6) | 0.971 |
1501–3000 | 21 (13.3%) | 33 (9.3%) | 1.5 (0.8–2.8) | 0.180 |
>3000 |
8 (5.1%) |
11 (3.1%) |
1.7 (0.6–4.6) |
0.282 |
Ever had sex | ||||
No | 137 (86.7%) | 301 (85.3%) | 1.1 (0.6–2.1) | 0.667 |
Yes | 14 (8.9%) | 41 (11.6%) | 0.7 (0.4–1.4) | 0.353 |
Not answered |
7 (4.4%) |
11 (3.1%) |
1.4 (0.5–4.2) |
0.456 |
Have heard of HPV infection | ||||
No/Not sure | 79 (50.0%) | 213 (60.3%) | 0.7 (0.4–0.9) | 0.029 |
Yes |
79 (50.0%) |
140 (39.7%) |
1.5 (1.0–2.3) |
0.029 |
Have heard of HPV vaccine | ||||
No/Not sure | 103 (65.2%) | 284 (80.5%) | 0.5 (0.3–0.7) | <0.001 |
Yes |
55 (34.8%) |
69 (19.5%) |
2.2 (1.4–3.4) |
<0.001 |
HPV and its vaccine knowledge score (Total 18 score) | ||||
<7 | 53 (33.5%) | 161 (45.6%) | 0.6 (0.4–0.9) | 0.011 |
≥7 | 105 (66.5%) | 192 (54.4%) | 1.7 (1.1–2.5) | 0.011 |
OR = unadjusted odds ratio; CI = confidence interval.